4R. Fujii,A. Seshimo,S. Kameoka. Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma[J] 2003,International Journal of Clinical Oncology(2):0072～0078
5Kazuhiro Yasuda MD,Yosuke Adachi MD,Norio Shiraishi MD,Kimio Yamaguchi MD,Yasuhiro Hirabayashi MD,Seigo Kitano MD. Pattern of Lymph Node Micrometastasis and Prognosis of Patients with Colorectal Cancer[J] 2001,Annals of Surgical Oncology(4):300～304
6R. Adam MD, PhD,E. Avisar MD,A. Ariche MD,S. Giachetti MD,D. Azoulay MD, PhD,D. Castaing MD,,F. Kunstlinger MD,F. Levi MD,F. Bismuth MD. Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases[J] 2001,Annals of Surgical Oncology(4):347～353
7Johannes Schüller,Jim Cassidy,Etienne Dumont,Brigitte Roos,Sarah Durston,Ludger Banken,Masahiro Utoh,Kazushige Mori,Erhard Weidekamm,Bruno Reigner. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients[J] 2000,Cancer Chemotherapy and Pharmacology(4):291～297
二级参考文献21
1Hayashi N,Ito I,Yanagisawa A,et al.Genetic diagnosis of lymph node metastases in colorectal cancer [J]. Lancet,1995,345(7):1257- 1262.
2Greenson JK,Isenhart CE,Rice R,et al. Identification of occult micrometastases in pericolic lymph node of Dukes B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49: correlation with long term survival [J]. Cancer,1994,73:563- 569.
3Futamura M,Takagi Y,Koumura H,et al. Spread of colorectal cancer micrometastases in regional lymph node by reserse transcriptase polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20 [J]. J Surg Oncol,1998,68:31- 40.
5Raj GV, Moreno JG, Gomella LG. Utilization of polymerase chain reaction technology in the detection of solid tumors [J]. Cancer, 1998, 82:1419- 1423.
6Dorudi S, Kinrade E, Marshall NC, et al. Genetic detection of lymph node micrometastases in patients with colorectal cancer [J]. Br J Surg, 1998, 85:98- 100.
7Bustin SA,Gyselman VG,Williams NS,et al.Detecection of cytokeratins19/20 and guanylyl cyclase C in peripheral blood of coloreactal cancer patients [J]. Brit J Cancer, 1999, 79(5)1813- 1819.
9Giantonio BJ,Catalano PJ,Meropol NJ,et al.High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer:Results from the Eastern Cooperative Oncology Group (ECOG) study E3200[ J].Pro Am Soc Clin Oncol,2005,23:1s Abstr 2.
10Sandler AB,Gray R,Brahmer J,et al.Randomized phase Ⅱ/Ⅲ trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab in patients with advanced non-squamous non-small cell lung cancer (NSCLC):An Eastern Cooperative Oncology Group (ECOG) trial-E4599 [ J].Pro Am Soc Clin Oncol,2005,23:2s LBA4.
9Mor V, Laliberte L, Morris JN, et al. The Karnof- sky Performance Status: an examination of its reliability and validity in a research setting [ J].Cancer, 1984,53(9):2002-2007.
